Cholecystokinin-octapeptide effects on conditioned-avoidance behavior, stereotypy and catalepsy

Steven L. Cohen, Martha Knight, Carol A. Tamminga, Thomas N. Chase

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

The effect of peripherally administered cholecystokinin-octapeptide (CCK8) was tested on signaled-avoidance behaviot, apomorphine-induced stereotypy, and catalepsy. Rats were trained to avoid shock in a signaled shuttle-box avoidance task, and then given CCK8, tetragastrin, or haloperidol. CCK8 (20-3840 μg/kg i.p.) reduced avoidance in a dose-dependent manner. The impairment at maximal dose levels was approximately 25% from its predrug level compared to 50% with haloperidol (100 μg/kg i.p.). Combined injection of CCK8 (320 μg/kg i.p.) and haloperidol (75 μg/kg i.p.) reduced avoidance significantly more than either drug alone. The effects of CCK8 were relatively brief in that active avoidance was impaired if CCK8 was injected up to 15 min before the avoidance test. CCK8 also facilitated the extinction of avoidance. Tetragastrin (177 μg/kg i.p.), which elicits gastrointestinal effects resembling CCK8, did not affect avoidance. In addition, CCK8 diminished apomorphine-induced stereotypy up to 5 min after CCK8 injection. CCK8 (20-1280 μg/kg i.p. and s.c.) failed to produce catalepsy in vertical grip tests. These data suggest that peripherally administered CCK8 has sedative and certain neuroleptic-like effects on behavior.

Original languageEnglish (US)
Pages (from-to)213-222
Number of pages10
JournalEuropean Journal of Pharmacology
Volume83
Issue number3-4
DOIs
StatePublished - Sep 24 1982

Fingerprint

Avoidance Learning
Catalepsy
Sincalide
Haloperidol
Tetragastrin
Apomorphine
Injections
Hand Strength
Hypnotics and Sedatives
Antipsychotic Agents
Shock
Pharmaceutical Preparations

Keywords

  • Avoidance
  • Catalepsy
  • Cholecystokinin-octapeptide
  • Dopamine
  • Neuroleptic
  • Stereotypy

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Cholecystokinin-octapeptide effects on conditioned-avoidance behavior, stereotypy and catalepsy. / Cohen, Steven L.; Knight, Martha; Tamminga, Carol A.; Chase, Thomas N.

In: European Journal of Pharmacology, Vol. 83, No. 3-4, 24.09.1982, p. 213-222.

Research output: Contribution to journalArticle

Cohen, Steven L. ; Knight, Martha ; Tamminga, Carol A. ; Chase, Thomas N. / Cholecystokinin-octapeptide effects on conditioned-avoidance behavior, stereotypy and catalepsy. In: European Journal of Pharmacology. 1982 ; Vol. 83, No. 3-4. pp. 213-222.
@article{98e0040c8e8d4f9cacd1000ff2cbcf95,
title = "Cholecystokinin-octapeptide effects on conditioned-avoidance behavior, stereotypy and catalepsy",
abstract = "The effect of peripherally administered cholecystokinin-octapeptide (CCK8) was tested on signaled-avoidance behaviot, apomorphine-induced stereotypy, and catalepsy. Rats were trained to avoid shock in a signaled shuttle-box avoidance task, and then given CCK8, tetragastrin, or haloperidol. CCK8 (20-3840 μg/kg i.p.) reduced avoidance in a dose-dependent manner. The impairment at maximal dose levels was approximately 25{\%} from its predrug level compared to 50{\%} with haloperidol (100 μg/kg i.p.). Combined injection of CCK8 (320 μg/kg i.p.) and haloperidol (75 μg/kg i.p.) reduced avoidance significantly more than either drug alone. The effects of CCK8 were relatively brief in that active avoidance was impaired if CCK8 was injected up to 15 min before the avoidance test. CCK8 also facilitated the extinction of avoidance. Tetragastrin (177 μg/kg i.p.), which elicits gastrointestinal effects resembling CCK8, did not affect avoidance. In addition, CCK8 diminished apomorphine-induced stereotypy up to 5 min after CCK8 injection. CCK8 (20-1280 μg/kg i.p. and s.c.) failed to produce catalepsy in vertical grip tests. These data suggest that peripherally administered CCK8 has sedative and certain neuroleptic-like effects on behavior.",
keywords = "Avoidance, Catalepsy, Cholecystokinin-octapeptide, Dopamine, Neuroleptic, Stereotypy",
author = "Cohen, {Steven L.} and Martha Knight and Tamminga, {Carol A.} and Chase, {Thomas N.}",
year = "1982",
month = "9",
day = "24",
doi = "10.1016/0014-2999(82)90254-0",
language = "English (US)",
volume = "83",
pages = "213--222",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "3-4",

}

TY - JOUR

T1 - Cholecystokinin-octapeptide effects on conditioned-avoidance behavior, stereotypy and catalepsy

AU - Cohen, Steven L.

AU - Knight, Martha

AU - Tamminga, Carol A.

AU - Chase, Thomas N.

PY - 1982/9/24

Y1 - 1982/9/24

N2 - The effect of peripherally administered cholecystokinin-octapeptide (CCK8) was tested on signaled-avoidance behaviot, apomorphine-induced stereotypy, and catalepsy. Rats were trained to avoid shock in a signaled shuttle-box avoidance task, and then given CCK8, tetragastrin, or haloperidol. CCK8 (20-3840 μg/kg i.p.) reduced avoidance in a dose-dependent manner. The impairment at maximal dose levels was approximately 25% from its predrug level compared to 50% with haloperidol (100 μg/kg i.p.). Combined injection of CCK8 (320 μg/kg i.p.) and haloperidol (75 μg/kg i.p.) reduced avoidance significantly more than either drug alone. The effects of CCK8 were relatively brief in that active avoidance was impaired if CCK8 was injected up to 15 min before the avoidance test. CCK8 also facilitated the extinction of avoidance. Tetragastrin (177 μg/kg i.p.), which elicits gastrointestinal effects resembling CCK8, did not affect avoidance. In addition, CCK8 diminished apomorphine-induced stereotypy up to 5 min after CCK8 injection. CCK8 (20-1280 μg/kg i.p. and s.c.) failed to produce catalepsy in vertical grip tests. These data suggest that peripherally administered CCK8 has sedative and certain neuroleptic-like effects on behavior.

AB - The effect of peripherally administered cholecystokinin-octapeptide (CCK8) was tested on signaled-avoidance behaviot, apomorphine-induced stereotypy, and catalepsy. Rats were trained to avoid shock in a signaled shuttle-box avoidance task, and then given CCK8, tetragastrin, or haloperidol. CCK8 (20-3840 μg/kg i.p.) reduced avoidance in a dose-dependent manner. The impairment at maximal dose levels was approximately 25% from its predrug level compared to 50% with haloperidol (100 μg/kg i.p.). Combined injection of CCK8 (320 μg/kg i.p.) and haloperidol (75 μg/kg i.p.) reduced avoidance significantly more than either drug alone. The effects of CCK8 were relatively brief in that active avoidance was impaired if CCK8 was injected up to 15 min before the avoidance test. CCK8 also facilitated the extinction of avoidance. Tetragastrin (177 μg/kg i.p.), which elicits gastrointestinal effects resembling CCK8, did not affect avoidance. In addition, CCK8 diminished apomorphine-induced stereotypy up to 5 min after CCK8 injection. CCK8 (20-1280 μg/kg i.p. and s.c.) failed to produce catalepsy in vertical grip tests. These data suggest that peripherally administered CCK8 has sedative and certain neuroleptic-like effects on behavior.

KW - Avoidance

KW - Catalepsy

KW - Cholecystokinin-octapeptide

KW - Dopamine

KW - Neuroleptic

KW - Stereotypy

UR - http://www.scopus.com/inward/record.url?scp=0019905704&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019905704&partnerID=8YFLogxK

U2 - 10.1016/0014-2999(82)90254-0

DO - 10.1016/0014-2999(82)90254-0

M3 - Article

C2 - 6129145

AN - SCOPUS:0019905704

VL - 83

SP - 213

EP - 222

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 3-4

ER -